Blood Sugar Sensing on Maintenance Dialysis

Patients with kidney failure treated by dialysis have high rates of adverse health outcomes, including cardiovascular events, infections, falls, and fractures.

High and low blood glucose may be risk factors for these poor outcomes that are modifiable with lifestyle and new pharmacologic interventions.

This project is a five-year competitive renewal from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) that will extend the original BLOSSOM (BLOod Sugar Sensing On Maintenance dialysis) study.

Researchers will apply state-of-the-art continuous glucose monitoring to dialysis patients to better understand blood glucose patterns and assess whether they are related to relevant health outcomes, filling critical gaps in knowledge that are necessary to design and evaluate new interventions to improve glycemia and related outcomes among people living with kidney failure.